Works matching IS 15493296 AND DT 2024 AND VI 112 AND IP 5


Results: 12
    1
    2
    3

    ROS‐mediated anticancer effects of EGFR‐targeted nanoceria.

    Published in:
    Journal of Biomedical Materials Research, Part A, 2024, v. 112, n. 5, p. 754, doi. 10.1002/jbm.a.37656
    By:
    • Johnson, Kochurani K.;
    • Koshy, Pramod;
    • Kopecky, Chantal;
    • Devadason, Michelle;
    • Biazik, Joanna;
    • Zheng, Xiaoran;
    • Jiang, Yue;
    • Wang, Xiaochun;
    • Liu, Yiling;
    • Holst, Jeff;
    • Yang, Jia‐Lin;
    • Kilian, Kristopher A.;
    • Sorrell, Charles C.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    Journal of Biomedical Materials Research, Part A, 2024, v. 112, n. 5, p. 635, doi. 10.1002/jbm.a.37566
    Publication type:
    Article